June 6, 2024
Insights from Bayer’s $1.5 Billion VC Fund | Lucio Iannone, Head of Health Venture Investments (VP) at Leaps by Bayer
Discover how Bayer's Leaps Venture Capital arm is transforming the biotech landscape by investing in cutting-edge therapies and technologies. Lucio Iannone, a leading investor at Leaps, shares insights into their unique approach and the future of healthcare.
Learn more about your ad choices. Visit megaphone.fm/adchoices